| Literature DB >> 15470604 |
Abstract
Novovax Inc has developed and launched Estrasorb, a transdermally absorbed, micro-encapsulated estradiol, as an estrogen replacement therapy for short-term use in the reduction of vasomotor symptoms in menopausal women. Estrasorb was launched in the US in April 2004.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15470604
Source DB: PubMed Journal: IDrugs ISSN： 1369-7056